Sesen Bio Inc.

NASDAQ: SESN · Real-Time Price · USD
0.63
0.04 (7.49%)
At close: Mar 07, 2023, 10:00 PM

Sesen Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 40M 26.54M
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a 40M 26.54M
Operating Income
n/a -25.91M -8.55M
Interest Income
n/a 1.85M n/a
Pretax Income
-60.48M -23.76M -8.61M
Net Income
-60.48M -19.88M -336K
Selling & General & Admin
22.14M 39.79M 29.39M
Research & Development
59.67M 38.59M 25.31M
Other Expenses
n/a 296K -60K
Operating Expenses
81.81M 78.38M 54.7M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 78.38M 54.7M
Income Tax Expense
n/a -3.88M -8.27M
Shares Outstanding (Basic)
41.46M 9.97M 9.12M
Shares Outstanding (Diluted)
41.46M 9.97M 9.12M
EPS (Basic)
-1.46 -1.99 -0.04
EPS (Diluted)
-1.46 -1.99 -0.04
EBITDA
n/a -50.84M -8.55M
EBIT
n/a -50.85M n/a
Depreciation & Amortization
n/a 13K -39.14M